PAPER Kac PR, Alcolea D, Montoliu-Gaya L, Fernandez S, LanteroRodriguez J, Maure L, Gonzalez-Ortiz F, Benejam B, Turton M, Barroeta I, Harrison P, Videla L, Ashton NJ, Lleo A, Zetterberg H, Carmona-Iragui M, Karikari TK, Fortea J, Blennow K

Plasma p-tau212 as a biomarker of sporadic and Down Syndrome Alzheimers disease

medRxiv2024.10.31.24316469 .

Teresa Gomez-Isla, W. Taylor Kimberly, Jeremy Ford on AI to Spot ARIA? FDA Says Yes

COMMENT This FDA authorization for an AI-driven MRI solution is an exciting step forward in assisting the detection of ARIA and supporting the safe administration of anti-amyloid therapies for Alzheimer's disease. However, it's important to note that th

Beyond Antibodies: From CTAD, New Attempts at Outflanking Alzheimer’s

CONFERENCE COVERAGE 2024-11-22 Conference Coverage Most Alzheimerologists agree that lecanemab and donanemab are a start, but insufficient to treat this disease. At the Clinical Trials in Alzheimer’s Disease conference, held last month in Madrid, scientists not only debated how to make

PAPER Tada H, Nomura A, Kawashiri MA, Takamura M

The First Japanese Case of Familial Hypercholesterolemia Caused by an APOE p.Leu167del Mutation: A Case Report.

Intern Med. 2024 Nov 21; Epub 2024 Nov 21 PubMed.

PAPER Shuja MH, Imran H, Abid M, Ibrahim Ahmed F

Evaluating Donanemab: Advances and Challenges in Alzheimer Disease Treatment.

Am J Ther. 2024 Nov 20; Epub 2024 Nov 20 PubMed.

PAPER Zhang XY, Zhang H, Bao QN, Yin ZH, Li YQ, Xia MZ, Chen ZH, Zhong WQ, Wu KX, Yao J, Liang FR

Diagnostic value of arterial spin labeling for Alzheimer's disease: A systematic review and meta-analysis.

PLoS One. 2024;19(11):e0311016. Epub 2024 Nov 21 PubMed.

PAPER Gleason CE, Dowling NM, Kara F, James TT, Salazar H, Ferrer Simo CA, Harman SM, Manson JE, Hammers DB, Naftolin FN, Pal L, Miller VM, Cedars MI, Lobo RA, Malek-Ahmadi M, Kantarci K

Long-term cognitive effects of menopausal hormone therapy: Findings from the KEEPS Continuation Study.

PLoS Med. 2024 Nov;21(11):e1004435. Epub 2024 Nov 21 PubMed.

PAPER Nielsen TR, Kjaergaard D

Primary Progressive Aphasia Across Languages: Prevalence and Presentation of Phenotypes Are Shaped by Language-Specific Features.

Neurology. 2024 Dec 24;103(12):e210165. Epub 2024 Nov 21 PubMed.

PAPER Wang Z, Zhou L, Zhao N, Zhang Z, Zhang J, Ren QG

Bidirectional Crosstalk between the Heart and Brain in Alzheimer's Disease.

Aging Dis. 2024 Nov 5; Epub 2024 Nov 5 PubMed.

PAPER Wang S, Jiang Y, Yang A, Meng F, Zhang J

The Expanding Burden of Neurodegenerative Diseases: An Unmet Medical and Social Need.

Aging Dis. 2024 Nov 9; Epub 2024 Nov 9 PubMed.

PAPER Gómez-Tortosa E, Agüero-Rabes P, Ruiz-González A, Wagner S, Téllez R, Mahillo I, Ruiz-Calvo A, Sainz MJ, Nystrom AL, Cremades-Jimeno L, Del Ser T, Sánchez-Juan P

Plasma Neurodegenerative Biomarkers in Cognitively Preserved Nonagenarians.

Aging Dis. 2024 Nov 6; Epub 2024 Nov 6 PubMed.

PAPER Kodali M, Madhu LN, Somayaji Y, Attaluri S, Huard C, Panda PK, Shankar G, Rao S, Shuai B, Gonzalez JJ, Oake C, Hering C, Babu RS, Kotian S, Shetty AK

Residual microglia following short-term PLX5622 treatment in 5xFAD mice exhibit diminished NLRP3 inflammasome and mTOR signaling, and enhanced autophagy.

Aging Cell. 2024 Nov 21;:e14398. Epub 2024 Nov 21 PubMed.

PAPER Zhou D, Lin Y, Han Z, Zhang Z, Lin L, Lin S, Yang Q

The Impact of Aging on Neurological Diseases in the Elderly: Molecular Mechanisms and Therapeutic Perspectives.

Aging Dis. 2024 Nov 12; Epub 2024 Nov 12 PubMed.

Jeremy Ford

Massachusetts General Hospital
Boston, United States

Open Rank Associate Professor/Professor in Data Science

JOB 2024-11-22 Employer Herbert and Jacqueline Krieger Klein Alzheimer’s Research Center at Rutgers University Principal Investigator Michal Schnaider Beeri Contact adrd@bhi.rutgers.edu Applicants representing diverse backgrounds of all sorts are encouraged to apply. Ru